Home » Dali Pharmaceutical: The company’s Xingnaojing injection and Shenmai injection were included in the sixth, seventh, eighth and ninth editions of the new crown diagnosis and treatment plan_ Oriental Fortune Network

Dali Pharmaceutical: The company’s Xingnaojing injection and Shenmai injection were included in the sixth, seventh, eighth and ninth editions of the new crown diagnosis and treatment plan_ Oriental Fortune Network

by admin
Dali Pharmaceutical: The company’s Xingnaojing injection and Shenmai injection were included in the sixth, seventh, eighth and ninth editions of the new crown diagnosis and treatment plan_ Oriental Fortune Network


Every time the AI ​​Express is sent, investors ask questions on the investor interaction platform: The company’s main products, Xingnaojing Injection and Shenmai Injection, have exact curative effects and high safety, and have played a unique role in the national anti-epidemic treatment process in 2020. Both were listed as recommended drugs in the sixth, seventh and eighth editions of the “Diagnosis and Treatment Program for Novel Coronavirus Pneumonia” by the National Health Commission and the State Administration of Traditional Chinese Medicine. Are Xingnaojing Injection and Shenmai Injection also included in the Plan? Thanks!

  Dali Pharmaceutical(603963.SH) stated on the investor interaction platform on March 18 that the company’s main products, Xingnaojing Injection and Shenmai Injection, were listed in the sixth and seventh editions by the National Health Commission and the State Administration of Traditional Chinese Medicine. , the eighth and ninth editions of the “New Coronary Virus Pneumonia Diagnosis and Treatment Program” recommended drugs.

(Article source: Daily Economic News)


Article source: Daily Economic News

Responsible editor: 92

Original title: Dali Pharmaceutical: The company’s Xingnaojing injection and Shenmai injection were included in the sixth, seventh, eighth and ninth editions of the new crown diagnosis and treatment plan

Solemnly declare: Oriental Fortune.com releases this information for the purpose of disseminating more information and has nothing to do with the position of this site.

report

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy